A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled "Hypoxia induced lipid droplet ...

In their study, published in Cell, the researchers identified 851 distinct N-acyl lipids across various tissues and biofluids, 777 of which had never been documented before.

The phase 3 sub-study tracked significant changes in an biomarker, adding to evidence that CETP inhibition may cut the risk of developing Alzheimer’s.

Scientists have developed a method for analysing the structure of lipid nanoparticles that could be used to improve vaccine and drug delivery, targeting a wide range of health issues.

Join an expert panel as they explore the dynamic landscape of lipid-based drug delivery systems (DDS) regarding the current research trends and innovation, followed by a deeper look into real-world ...

Lipid-based communication between body and gut microbes can trigger beneficial immune responses by Chinese Academy of Sciences Editors' notes ...

Phase III trial data support obicetrapib's lipid controlling effects in high-risk individuals without sufficient response to other lipid-lowering therapies. Obicetrapib is a highly selective CETP ...

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR In this webinar, Nathan Sepulveda will share how to specifically and reproducibly measure residual HEK293 DNA during biotherapeutic ...

Obicetrapib is a highly selective cholesteryl ester transfer protein inhibitor that reduces low-density lipoprotein (LDL) cholesterol levels. The efficacy and safety of obicetrapib have not been fu ...

Together, these data identify cholesterol in liver lipid droplets as a critical mediator of MASH and demonstrate that Coenzyme A synthase knockdown and bempedoic acid are therapeutic approaches to ...

Oregon Health & Science University, in collaboration with Oregon State University, has discovered the structural organization and protein components of a lipid-transfer complex known as LPD-3 ...

CHICAGO — Two novel agents targeting angiopoietin-like protein 3 demonstrated safety and lipid-lowering capabilities in phase 2 trials, according to findings presented at the American ...